Patent · US Active

Recombinant Bacillus subtilis and use thereof

US11136545B2 · kind B2 · utility

0Cited by
0References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 18, 2018
Grant dateOct 5, 2021
Priority date
Expiry dateApr 16, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y206/01016
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides a recombinant Bacillus subtilis, construction method and use thereof, wherein the cell's own FMMs are used as a space scaffold, and a multi-enzyme complex is constructed from specific marker proteins FloA and FloT, such that an artificial substrate channel is formed, and the cell metabolic burden is effectively reduced. The recombinant Bacillus subtilis of the invention can efficiently synthesize GlcNAc without affecting cell life activity, and can also limit the toxic intermediate metabolite GlcN-6-P near the plasma membrane to reduce or eliminate its inhibition on cell activity. In the process of shaking flask fermentation using complex medium, the yield of acetyl glucosamine of the control strain BSG-C was only 0.45 g·L−1, while that of BSG-AT, BSG-ATP, BSG-ATPB increased to 5.29 g·L−1, 6.22 g·L−1 and 8.48 g·L−1 respectively. The construction method of recombinant Bacillus subtilis is simple, easy to use and has a good application prospect.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.